TERUMO CORPORATION |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 2,670 JPY | +1.91% |
|
+0.95% | +15.53% |
| May. 28 | Terumo Cardiovascular Announces 510(K) Clearance for the CDI Oneview?? Monitoring System | CI |
| May. 15 | Correction: Terumo’s Profit Up 47% in Fiscal 2024 | MT |
| Sales 2024 | 922B 5.86B | Sales 2025 * | 991B 6.3B | Capitalization | 3,964B 25.19B |
|---|---|---|---|---|---|
| Net income 2024 | 106B 676M | Net income 2025 * | 127B 805M | EV / Sales 2024 | 4.4 x |
| Net Debt 2024 * | 23.33B 148M | Net cash position 2025 * | 52.98B 337M | EV / Sales 2025 * | 3.95 x |
| P/E ratio 2024 |
38.2
x | P/E ratio 2025 * |
31.3
x | Employees | 30,207 |
| Yield 2024 |
0.81% | Yield 2025 * |
0.96% | Free-Float | 95.4% |
More Fundamentals
* Assessed data
More news
Latest transcript on Terumo Corporation
More recommendations
More press releases
More news
| 1 day | +1.91% | ||
| 1 week | +0.95% | ||
| 1 month | -0.87% | ||
| 3 months | -8.50% | ||
| 6 months | +13.18% | ||
| Current year | +15.53% |
1 week
2 542.50
2 715.00
1 month
2 542.502 816.50
Current year
2 267.003 014.50
1 year
1 856.003 014.50
3 years
1 708.003 014.50
5 years
1 440.003 014.50
10 years
530.753 014.50
| Managers | Title | Age | Since |
|---|---|---|---|
Toshiaki Takagi
CHM | Chairman | 66 | 81-03-31 |
Naoki Muto
DFI | Director of Finance/CFO | - | - |
Kazuhisa Senshu
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shouji Hatano
CMP | Compliance Officer | 64 | 83-03-31 |
Hidenori Nishi
BRD | Director/Board Member | 73 | 20-06-24 |
Shinjiro Sato
BRD | Director/Board Member | 63 | 04-05-31 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 2.24% | 32 M€ | +15.69% | ||
| 1.94% | 28,258 M€ | +15.99% | - | |
| 1.90% | 15,324 M€ | +15.05% | - | |
| 1.82% | 64,792 M€ | +15.98% |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-31 | 2,670 | +1.91% | 7,797,900 |
| 24-05-30 | 2,620 | -2.75% | 4,722,500 |
| 24-05-29 | 2,694 | +0.17% | 2,239,900 |
| 24-05-28 | 2,690 | -0.37% | 1,622,000 |
| 24-05-27 | 2,700 | +2.06% | 1,815,000 |
Delayed Quote Japan Exchange, May 31, 2024 at 02:00 am EDT
More quotes
Terumo Corporation specializes in the design, manufacturing and marketing of medical products and equipments. Net sales break down by family of products as follows:
- cardiac surgery devices (53.5%);
- medical products for hospitals (28.6%): medical devices, nutritional additives, oxygen, medical measuring devices (thermometers, tensiometers, glucometers, etc.), etc.;
- sanguine transfusion equipments (17.9%).
Net sales break down geographically as follows: Japan (32.9%), America (29.5%), Europe (19.6%), China (7.4%) and other (10.6%).
Calendar
2024-08-06
- Q1 2024 Earnings Release (Projected)
Trading Rating
Investor Rating
ESG Refinitiv
A-
Sell
Buy
Mean consensus
BUY
Number of Analysts
14
Last Close Price
2,670
JPY
Average target price
3,082
JPY
Spread / Average Target
+15.41%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +15.53% | 25.22B | |
| -7.16% | 178B | |
| -4.86% | 67.04B | |
| -4.28% | 47.24B | |
| +10.32% | 44.62B | |
| +8.14% | 42.5B | |
| +15.76% | 29.99B | |
| -5.88% | 24.14B | |
| -5.38% | 23.69B | |
| +1.38% | 22.04B |
- Stock Market
- Equities
- 4543 Stock
